Novel Genetic Risk and Metabolic Signatures of Insulin Signaling and Androgenesis in the Anovulation of Polycystic Ovary Syndrome
| dc.contributor.author | Wu, Xiaoke | |
| dc.contributor.author | Wang, Chi Chiu | |
| dc.contributor.author | Cao, Yijuan | |
| dc.contributor.author | Li, Jian | |
| dc.contributor.author | Li, Zhiqiang | |
| dc.contributor.author | Ma, Hongli | |
| dc.contributor.author | Gao, Jingshu | |
| dc.contributor.author | Chang, Hui | |
| dc.contributor.author | Zhang, Duojia | |
| dc.contributor.author | Cong, Jing | |
| dc.contributor.author | Wang, Yu | |
| dc.contributor.author | Wu, Qi | |
| dc.contributor.author | Han, Xiaoxiao | |
| dc.contributor.author | Chung, Pui Wah Jacqueline | |
| dc.contributor.author | Li, Yiran | |
| dc.contributor.author | Zheng, Xu | |
| dc.contributor.author | Chen, Lingxi | |
| dc.contributor.author | Zeng, Lin | |
| dc.contributor.author | Borchert, Astrid | |
| dc.contributor.author | Kuhn, Hartmut | |
| dc.contributor.author | Chen, Zi Jiang | |
| dc.contributor.author | Ng, Ernest Hung Yu | |
| dc.contributor.author | Stener-Victorin, Elisabet | |
| dc.contributor.author | Zhang, Heping | |
| dc.contributor.author | Legro, Richard S. | |
| dc.contributor.author | Mol, Ben Willem J. | |
| dc.contributor.author | Shi, Yongyong | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
| dc.date.accessioned | 2023-07-24T13:10:01Z | |
| dc.date.available | 2023-07-24T13:10:01Z | |
| dc.date.issued | 2023-04 | |
| dc.description | Funding Information: The authors are grateful to all staff in the PCOSAct group for their effort in the collection of blood samples and clinical dataset which used in current study. Special thanks to Prof. Attila Toth from Institute of Physiological Chemistry, Dresden, Germany for the REC114 antibody. This study was supported by the National key Research and Development Program of China (2019YFC1709500); the National Collaboration Project of Critical Illness by Integrating Chinese Medicine and Western Medicine; the Project of Heilongjiang Province Innovation Team “TouYan;” the Yi-Xun Liu and Xiao-Ke Wu Academician Workstation; the Innovation Team of Reproductive Technique with Integrative Chinese Medicine and Western Medicine in Xuzhou City, China; Heilongjiang University of Chinese Medicine from the National Clinical Trial Base; Heilongjiang Provincial Clinical Research Center for Ovary Diseases; the Research Grant Council (T13-602/21-N, C5045-20EF, and 14122021); and Food and Health Bureau in Hong Kong, China (06171026). Ben Willem J. Mol is supported by a National Health and Medical Research Council (NHMRC) Investigator grant (GNT1176437). Ben Willem J. Mol reports consultancy for ObsEva and Merck and travel support from Merck. Xiaoke Wu, Yongyong Shi, and Chi Chiu Wang developed the research question and designed the study. Xiaoke Wu, Yongyong Shi, Yijuan Cao, and Chi Chiu Wang designed the analysis. Yongyong Shi and Zhiqiang Li contributed to the design of the experiment of whole-exome plus targeted SNP sequencing and the analysis, and interpreted the results. Jingshu Gao, Hui Chang, Duojia Zhang, Jing Cong, Yu Wang, Qi Wu, Xiaoxiao Han, Pui Wah Jacqueline Chung, Yiran Li, and Lin Zeng contributed to the experiment of metabolic profile and immunofluorescent staining and the analysis, and interpreted the results. Astrid Borchert and Hartmut Kuhn provided antibody support and advice. Xu Zheng and Lingxi Chen contributed to create the predictive model with deep machine learning. Jian Li, Qi Wu, Hongli Ma, Xu Zheng, and Lingxi Chen contributed to the analysis of the clinical characteristics and interpreted the results. Jian Li, Hongli Ma, Hui Chang, Jing Cong, and Chi Chiu Wang drafted the manuscript. All authors reviewed and revised the manuscript. Xiaoke Wu is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Xiaoke Wu, Chi Chiu Wang, Yijuan Cao, Jian Li, Zhiqiang Li, Hongli Ma, Jingshu Gao, Hui Chang, Duojia Zhang, Jing Cong, Yu Wang, Qi Wu, Xiaoxiao Han, Pui Wah Jacqueline Chung, Yiran Li, Xu Zheng, Lingxi Chen, Lin Zeng, Astrid Borchert, Hartmut Kuhn, Zijiang Chen, Ernest Hung Yu Ng, Elisabet Stener-Victorin, Heping Zhang, Richard S. Legro, Ben Willem J. Mol, and Yongyong Shi declare that they have no conflict of interest or financial conflicts to disclose. Funding Information: This study was supported by the National key Research and Development Program of China ( 2019YFC1709500 ); the National Collaboration Project of Critical Illness by Integrating Chinese Medicine and Western Medicine ; the Project of Heilongjiang Province Innovation Team “TouYan;” the Yi-Xun Liu and Xiao-Ke Wu Academician Workstation; the Innovation Team of Reproductive Technique with Integrative Chinese Medicine and Western Medicine in Xuzhou City , China; Heilongjiang University of Chinese Medicine from the National Clinical Trial Base ; Heilongjiang Provincial Clinical Research Center for Ovary Diseases ; the Research Grant Council ( T13-602/21-N , C5045-20EF , and 14122021 ); and Food and Health Bureau in Hong Kong, China ( 06171026 ). Publisher Copyright: © 2023 | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 9 | |
| dc.format.extent | 2336596 | |
| dc.identifier | 266353761 | |
| dc.identifier | b4def95e-efb8-4d1f-b2fa-8c42d5585afc | |
| dc.identifier | 85141319191 | |
| dc.identifier.citation | Wu, X, Wang, C C, Cao, Y, Li, J, Li, Z, Ma, H, Gao, J, Chang, H, Zhang, D, Cong, J, Wang, Y, Wu, Q, Han, X, Chung, P W J, Li, Y, Zheng, X, Chen, L, Zeng, L, Borchert, A, Kuhn, H, Chen, Z J, Ng, E H Y, Stener-Victorin, E, Zhang, H, Legro, R S, Mol, B W J & Shi, Y 2023, 'Novel Genetic Risk and Metabolic Signatures of Insulin Signaling and Androgenesis in the Anovulation of Polycystic Ovary Syndrome', Engineering, vol. 23, pp. 103-111. https://doi.org/10.1016/j.eng.2022.08.013 | en |
| dc.identifier.doi | 10.1016/j.eng.2022.08.013 | |
| dc.identifier.issn | 2095-8099 | |
| dc.identifier.uri | https://hdl.handle.net/2164/21288 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85141319191&partnerID=8YFLogxK | en |
| dc.identifier.vol | 23 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Engineering | en |
| dc.subject | Deep machine learning | en |
| dc.subject | Infertility | en |
| dc.subject | Ovulation responses | en |
| dc.subject | Polycystic ovary syndrome | en |
| dc.subject | REC114 | en |
| dc.subject | Whole-exome sequencing | en |
| dc.subject | ZNF438 | en |
| dc.subject | QA75 Electronic computers. Computer science | en |
| dc.subject | General Computer Science | en |
| dc.subject | Environmental Engineering | en |
| dc.subject | General Chemical Engineering | en |
| dc.subject | Materials Science (miscellaneous) | en |
| dc.subject | Energy Engineering and Power Technology | en |
| dc.subject | General Engineering | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | QA75 | en |
| dc.title | Novel Genetic Risk and Metabolic Signatures of Insulin Signaling and Androgenesis in the Anovulation of Polycystic Ovary Syndrome | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
